Benefits of breast cancer screening outweigh the harms, study shows
Routine breast cancer screening saves the lives of two women for every one who receives unnecessary treatment, a study suggests today.
Read more on Times Online
Benefits of breast cancer screening outweigh the harms, study shows
Routine breast cancer screening saves the lives of two women for every one who receives unnecessary treatment, a study suggests today.
Read more on Times Online
Long term, tamoxifen stops more cancer than Evista
Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co’s Evista, but with a greater risk of some other cancers and blood clots.
Read more on Reuters via Yahoo! News